Switzerland cannabis pilots are testing regulated pharmacy access against prohibition’s warnings. New SCRIPT interim results found no increase in consumption frequency among regular adult users and signs of lower-risk consumption, while a separate one-year pharmacy study found no mental-health deterioration. Pot Culture Magazine examines what the evidence says, and what it does not prove.